Blacks currently represent about 20% of patients living with multiple myeloma. Experimental trials using immunotherapy to treat cancers such as multiple myeloma and melanoma skin cancer have yielded promising results. A new approach to immune therapy for cancer could be a “game changer.”
Currently, disabled viruses are used to carry new genetic material into immune cells called T cells in order to get them to target cancer. But these disabled viruses are in short supply, resulting in long wait times for them, the Washington Post reported.
A team of scientists says they’ve developed a new, faster method to reprogram T cells, which normally target bacterial or fungal infections, into cancer fighters.
Rather than using disabled viruses, the scientists found that shocking